Sadly, the US and other advanced countries have been pressing for stronger intellectual-property regimes around the world. Such regimes would limit poor countries’ access to the knowledge that they need for their development – and would deny life-saving generic drugs to the hundreds of millions of people who cannot afford the drug companies’ monopoly prices.
悲哀地是，美国和其它发达国家一直以来都在全世界范围内推动更强势的知识产权管制。这种制度会限制贫穷国家得到那些发展所需的知识——并且会让数以亿计支付不起药物公司垄断价格的人们无法得到用来救命的非专利药物。